SEELY LYNN sold 13.0% of their position (9.59K shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $149.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/25/2026ACC: 0001327111-26-000006
-9.59K
Net shares
Net seller
$149.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.59K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.59K
Price / share
$15.54
Trade value
$149.01K
% of position
13.0%
8/21/2026
73.49K→63.90K
Total
Net shares
−9.59K
Net value
-$149.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2026 | S · Sale | −9.59K | $15.54 | $149.01K | 13.0% | 73.49K | 63.90K |
| Total | −9.59K | -$149.01K | ||||||
Derivative Transactions0
No derivative transactions reported